Empowering Quebec's RNA Therapy Workforce

In collaboration with the Consortium Québécois sur la Découverte du Médicament (CQDM), CASTL is developing a state-of-the-art training program to meet the growing needs of the RNA therapeutics sector in Quebec: the Factory School.

With the rapid advancements in RNA therapy and Quebec's strong research expertise, this initiative is designed to equip the sector with a highly skilled workforce ready to meet the demands of this burgeoning industry. The RNA Therapies Factory School will provide specialized training programs designed to enhance knowledge and skills for RNA therapeutics production.

Losange
logo-cqdm

A Real-World
Training Environment

CASTL’s state-of-the-art facility mirrors the reality
of RNA therapeutics manufacturing, offering:

  • Training in Good Manufacturing Practices (GMP)
  • Hands-on experience in a GMP-simulated environment
  • Access to cutting-edge equipment for RNA therapeutic manufacturing, including purification and lipid nanoparticle encapsulation
  • Integration with existing CASTL facilities, which currently support monoclonal antibody production

Comprehensive
Training Programs

The RNA therapy factory-school will offer
a blended learning approach combining :

icon_interview-skills

Clasrroom-based
theoretical instruction

group

Virtual training modules

group

Programs covering
the full professional 
continuum from DEP
to PhD

Key objectives

Building Strategic Partnerships

CASTL will help establish a robust RNA therapy manufacturing ecosystem in Quebec through strong collaborations with key industry and academic partners. Our goal is to foster an environment that promotes knowledge sharing, talent development, and innovation.

To find out more about this initiative,
visit the Pôle AReNA du Québec website

arena logo@4x

For more information
fill in this form